Delivery Order SPE2DB22D1106-SPE2DB24FFFJ8

Award Date 8/5/24
Potential Completion Date 8/6/24
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,811.42 firm fixed-price delivery order is for the supply of a medical product, specifically 4565800881 ! SOL IV 0.9% NACL 100ML 1 DS PWDR DRG VL. The contract has an ultimate completion date of September 16, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with government agencies, including a...
This federal contract award, with an ID of SPE2DX15D1022|SPE2DX24FVLSF, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,598.92 firm fixed-price delivery order is for the supply of 4565377982 ! SOL IV 0.9% NACL 100ML 1 DS PWDR DRG VL, with an ultimate completion date of August 8, 2024. This contract is not designated as a set-aside. Amerisourcebergen is a major pharmaceutical distributor that holds several...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,680.53, is for the supply of various medical products including 4567219501 ! SOL IV 0.9% NACL 500ML PLS CNTNR VFLX LF. The contract has an ultimate completion date of February 11, 2025 and is a firm fixed-price type. Amerisourcebergen Drug Corp is the prime contractor, and there...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,221.95 firm fixed price delivery order is for the supply of a pharmaceutical product, 4564139590 ! SOL IV 3% NACL 500ML PLS CNTNR VFLX LF. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,470.33 firm fixed-price delivery order is for the supply of a specific medical product, 4562101570 - SOL IV 0.9% NACL 100ML 1 DS PWDR DRG VL. The award does not have a set-aside designation, indicating open competition. The prime contractor, Amerisourcebergen Drug Corp, is a subsidiary of the parent company...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,385.02, is a Firm Fixed Price Delivery Order for the procurement of 4560588184 ! SOL IV 0.9% NACL 10ML DEHP-FR PRSV FR 1. The contract has an ultimate completion date of April 17, 2023. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $4,325.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026. This IDC serves as a vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4563895647 - SOL IV 0.9% NACL 100ML 1 DS PWDR DRG VL. The contract has a potential value of $1,598.92 and a completion date of March 8, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this award, which does not utilize any set-aside...
This federal contract award is a Delivery Order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,328.29 Firm Fixed Price contract is for the delivery of 4560762542 - SOL IV 0.9% NACL 500ML PLS CNTNR VFLX LF medical products. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor for this award, which is...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as the prime contractor. The award is a delivery order (SPE2DX15D1208|SPE2DX24FLATF) with a firm fixed price of $1,151.03 and an ultimate completion date of March 22, 2024. The contract is for the supply of a pharmaceutical product, 4564035814 ! SOL IV 0.9% NACL 500ML PLS CNTNR VFLX LF, to support military treatment...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFFJ8
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,798.11 firm fixed price delivery order is for the supply of 4565346610 ! SOL IV 0.9% NACL 100ML 1 DS PWDR DRG VL. The contract has an ultimate completion date of August 6, 2024 and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation for providing a wide range of critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, medical supplies, and equipment to support military treatment programs, veterans' healthcare, and other federal healthcare initiatives.

Generated 11/4/24, 11:32 AM